Table 2.

Baseline characteristics of evaluable patients (n = 137)

CharacteristicPlacebo (n = 67)Fenretinide (n = 70)
Age (y) mean, median, range69.2, 70.9, 43.4-84.764.5, 64.0, 39.8-87.5
Gender
    Male5558
    Female1212
Race
    Black21
    Hispanic30
    Asian10
    White5966
    Other23
TCC characteristics
    Ta grade 1, grade 2 (no prior BCG)
        Solitary3433
        Multifocal1517
    Intermediate-risk, high-risk (prior BCG)1820
Smoking status
    Current1616
    Former3739
    Never1415